Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects

Study Identifier
P16-052
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Dermatology - Hidradenitis Suppurativa (HS)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years

    Protocol Summary

    The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

    Study Locations

    Location
    Status
    Location
    Kyungpook National Univ Hosp /ID# 162930
    Daegu, Daegu Gwang Yeogsi, Republic of Korea, 41944
    Status
    Not applicable
    Location
    Seoul National Univ Bundang ho /ID# 202254
    Seongnam, Gyeonggido, Republic of Korea, 13620
    Status
    Not applicable
    Location
    CHA Bundang Medical center, CHA University /ID# 203364
    Seongnam-si, Gyeonggido, Republic of Korea, 13496
    Status
    Not applicable
    Location
    Ajou University Hospital /ID# 163243
    Suwon, Gyeonggido, Republic of Korea, 16499
    Status
    Not applicable
    Location
    Chonnam National University Hospital /ID# 162932
    Gwangju, Jeonranamdo, Republic of Korea, 61469
    Status
    Not applicable
    Location
    Yonsei University Health System, Severance Hospital /ID# 162933
    Seodaemun-gu, Seoul Teugbyeolsi, Republic of Korea, 03722
    Status
    Not applicable
    Showing {first} - {last} of {total} Results